Literature DB >> 16818603

A positive feedback loop couples Ras activation and CD44 alternative splicing.

Chonghui Cheng1, Michael B Yaffe, Phillip A Sharp.   

Abstract

The Ras signaling pathway is important in both cell proliferation and tumor progression. Alternatively spliced isoforms of CD44 containing variable exon 6 (v6) can serve as coreceptors for growth factor receptors that activate Ras. Here we use v6-specific small interfering RNA (siRNA) to investigate the role of CD44 alternative splicing in Ras signaling. We identify a positive feedback loop in which Ras signaling promotes CD44v6 splicing, and CD44v6 then sustains late Ras signaling, which is important for cell cycle progression. These results are the first demonstration of a positive feedback loop linking signaling-dependent alternative splicing to mitogenic progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818603      PMCID: PMC1522067          DOI: 10.1101/gad.1430906

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  25 in total

Review 1.  Growth factor-dependent signaling and cell cycle progression.

Authors:  S M Jones; A Kazlauskas
Journal:  FEBS Lett       Date:  2001-02-16       Impact factor: 4.124

2.  CD44 is required for two consecutive steps in HGF/c-Met signaling.

Authors:  Véronique Orian-Rousseau; Linfeng Chen; Jonathan P Sleeman; Peter Herrlich; Helmut Ponta
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

Review 3.  CD44: from adhesion molecules to signalling regulators.

Authors:  Helmut Ponta; Larry Sherman; Peter A Herrlich
Journal:  Nat Rev Mol Cell Biol       Date:  2003-01       Impact factor: 94.444

4.  CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.

Authors:  Wei-Hsuan Yu; J Frederick Woessner; John D McNeish; Ivan Stamenkovic
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

5.  Signal-dependent regulation of splicing via phosphorylation of Sam68.

Authors:  Nathalie Matter; Peter Herrlich; Harald König
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

6.  Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway.

Authors:  S Weg-Remers; H Ponta; P Herrlich; H König
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

7.  Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion.

Authors:  Chonghui Cheng; Phillip A Sharp
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

8.  Growth-factor-dependent mitogenesis requires two distinct phases of signalling.

Authors:  S M Jones; A Kazlauskas
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

9.  Molecular interpretation of ERK signal duration by immediate early gene products.

Authors:  Leon O Murphy; Sallie Smith; Rey-Huei Chen; Diane C Fingar; John Blenis
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

10.  CD44 enhances neuregulin signaling by Schwann cells.

Authors:  L S Sherman; T A Rizvi; S Karyala; N Ratner
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

View more
  73 in total

1.  Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A.

Authors:  Wei Wang; Honghong Zhang; Sali Liu; Chung Kwon Kim; Yilin Xu; Lisa A Hurley; Ryo Nishikawa; Motoo Nagane; Bo Hu; Alexander H Stegh; Shi-Yuan Cheng; Chonghui Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

2.  Transition dependency: a gene-gene interaction measure for times series microarray data.

Authors:  Xin Gao; Daniel Q Pu; Peter X-K Song
Journal:  EURASIP J Bioinform Syst Biol       Date:  2009-02-05

Review 3.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

Review 4.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

5.  A systems view of the protein expression process.

Authors:  Sucheta Gokhale; Dimpal Nyayanit; Chetan Gadgil
Journal:  Syst Synth Biol       Date:  2011-10-19

Review 6.  Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.

Authors:  Carmen Berasain; María Elizalde; Raquel Urtasun; Josefa Castillo; Oihane García-Irigoyen; Iker Uriarte; Maria U Latasa; Jesús Prieto; Matías A Avila
Journal:  Hepat Oncol       Date:  2014-03-20

7.  Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease.

Authors:  Shibnath Ghatak; Galina S Bogatkevich; Ilia Atnelishvili; Tanjina Akter; Carol Feghali-Bostwick; Stanley Hoffman; Victor M Fresco; John C Fuchs; Richard P Visconti; Roger R Markwald; Subhas B Padhye; Richard M Silver; Vincent C Hascall; Suniti Misra
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

8.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

9.  PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells.

Authors:  Tong Zhang; Xian-Hong Huang; Lan Dong; Deqing Hu; Changhui Ge; Yi-Qun Zhan; Wang-Xiang Xu; Miao Yu; Wei Li; Xiaohui Wang; Liujun Tang; Chang-Yan Li; Xiao-Ming Yang
Journal:  Mol Cancer       Date:  2010-04-02       Impact factor: 27.401

10.  Global regulation of alternative splicing during myogenic differentiation.

Authors:  Christopher S Bland; Eric T Wang; Anthony Vu; Marjorie P David; John C Castle; Jason M Johnson; Christopher B Burge; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2010-07-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.